We are shaping the future of medicine from the Ruhr region to Ostwestfalen-Lippe.
University Medical Center Bochum, which consists of the Faculty of Medicine and eight supporting clinics, supported by numerous teaching hospitals, we combine practical teaching, innovative research and the direct application of our findings in clinical practice. Together, we are working on the cutting-edge medicine of tomorrow - for committed students, a sustainable society and strong healthcare provision throughout the region.
The curriculum of our integrated reform medicine (iRM) degree program places particular emphasis on interdisciplinarity and practical relevance. This flexible and future-oriented education optimally prepares our students for the medical challenges of tomorrow.
Our research excels in basic research, translational science, and clinical studies, with a focus on protein sciences, oncology, and neuroscience. Following the 'From Bench to Bedside' approach, we translate laboratory findings directly into clinical applications, setting global standards.
Through the diversity of our partner hospitals and academic teaching hospitals, we position ourselves strongly in clinical education, research, and patient care. This close collaboration makes us one of the largest and most efficient university hospitals in Germany, ensuring excellent training and top-quality patient care.
LWL University Hospital Bochum is launching OMPRIS as a permanent online therapy programme for adults with problematic internet, gaming or smartphone use. The programme supports patients in changing their behaviour
Miniature Muscles Advance Research into Rare Diseases
A new lab system at BG University Hospital Bergmannsheil grows three-dimensional muscle organoids. Researchers use these miniature models to analyze disease mechanisms and test innovative therapies.
Bochum University Medicine is among the pioneers of CAR T-cell therapy for myasthenia gravis. New long-term data show that the effects of a single treatment can persist for years in the patients studied.
PD Dr Felix Kleefeld has received the 2026 Felix Jerusalem Prize for his research into inclusion body myositis. His findings reveal early mitochondrial damage and could open new avenues for treatment.